Since 2000, more than 470,000 deaths in America have been attributed to both legal and illegal opioids, and many more people have been impacted through addiction. There have been nearly 135,000 personal injury claims against OxyContin maker Purdue Pharma LP over opioid addiction or overdose deaths, and in March it was revealed that Purdue Pharma's Chapter 11 bankruptcy filing has a $10 billion (£7.2bn) plan that will see it put its profits into trying to help solve America's opioid crisis. This includes around $4.3 billion (£3.1bn) given by the Sackler family, which owns the pharmaceutical giant, that grants them immunity from future claims. As part of this, Purdue Pharma will pay personal injury claimants as much as $48,000 (£35k) out of a dedicated $750 million (£542m) fund. That said, payouts will depend on the level of an individual’s injury or addiction, with the least severe cases receiving an estimated $3,500 (£2.5k). This plan has now been approved by a judge. However, the US Justice Department is appealing the bankruptcy plan's approval.